Page last updated: 2024-10-24

busulfan and Hepatic Failure

busulfan has been researched along with Hepatic Failure in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Secondary hemophagocytic syndrome (HPS) has been described after autologous hematopoietic cell transplant (AutoHCT)."1.51Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastoma. ( Cervi, D; Epperly, R; Federico, S; Furman, W; Hines, M; Li, Y; Madden, R; Mamcarz, E; Santiago, T; Talleur, A; Triplett, B, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Epperly, R1
Furman, W1
Hines, M1
Santiago, T1
Li, Y1
Madden, R1
Mamcarz, E1
Cervi, D1
Federico, S1
Triplett, B1
Talleur, A1
Duchartre, Y1
Petit, N1
Moya, C1
Lalanne, M1
Dubus, P1
Verneuil, Hd1
Moreau-Gaudry, F1
Richard, E1

Other Studies

2 other studies available for busulfan and Hepatic Failure

ArticleYear
Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastoma.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:11

    Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Chil

2019
Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
    Journal of hepatology, 2011, Volume: 55, Issue:1

    Topics: Animals; Animals, Newborn; Bone Marrow Transplantation; Busulfan; Disease Models, Animal; Disease Pr

2011